With a market cap of has a large market cap size. Biogen Inc. (NASDAQ: BIIB) has been on the stock market since its IPO date on the 9/17/1991. Biogen Inc. is in the Biotechnology industry and Healthcare sector. Average volume for Biogen Inc., is 2086.72, and so far today it has a volume of 489503. Performance year to date since the 9/17/1991 is 2.29%.
To help you determine whether Biogen Inc. is undervalued the following values will help you decide. P/E is 18.3 and forward P/E is 14.98. PEG perhaps more useful shows that Biogen Inc. has a value for PEG of 1.93. P/S ratio is 6.12 and the P/B ratio is 6.02. The P/Cash and P/Free cash flow is 18.12 and 21.39 respectively.
At the current price Biogen Inc. is trading at, 317.6 (1.35% today), Biogen Inc. has a dividend yield of *TBA, and this is covered by a payout ratio of 0.00%. Earnings per share (EPS) is 17.13, and this is looking to grow in the next year to 4.72% after growing 24.00% this past year. EPS growth quarter over quarter is 21.60%, and 11.70% for sales growth quarter over quarter.
The number of shares outstanding is 219.5, and the number of shares float is 218.5. The senior management bring insider ownership to 0.10%, and institutional ownership is at 87.80%. The float short is 1.17%, with the short ratio at a value of 1.23. Management has seen a return on assets of 18.50%, and also a return on investment of 23.50%.
The ability for Biogen Inc., to deal with debt, means it current ratio is 3, and quick ratio is 2.6. Long term debt/equity is 0.57 and total debt/equity is 0.57. In terms of margins, Biogen Inc. has a gross margin of 88.20%, with its operating margin at 47.90%, and Biogen Inc. has a profit margin of 34.00%.
The 52 week high is -4.81%, with 42.41% being its 52 week low. The 20 day simple moving average is 17.54% and the 200 day simple moving average is 16.19%.
Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.